Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, December 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 10 X users
facebook: 1 Facebook page

wikipedia: 15 Wikipedia pages

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 127 Mendeley
citeulike: 1 CiteULike

Summary X Facebook Wikipedia Dimensions citations

So far, Dimensions has found 40 publications that cite this research output.

40

The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study

Article in International Journal of Chronic Obstructive Pulmonary Disease (November 2021)

Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study

Article in International Journal of Chronic Obstructive Pulmonary Disease (December 2020)

Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)

Article in Cochrane Database of Systematic Reviews (December 2018)